What is Specialty PharmaSource?
Founded in 2016, Specialty PharmaSource specializes in providing critical pharmaceutical sourcing services for bioequivalence studies and clinical trials. Their offerings encompass clinical supplies sourcing, sterile injectable manufacturing, and expert consulting on regulatory compliance and drug shortage mitigation. By integrating U.S.-based regulatory acumen with a worldwide operational reach, the company ensures the delivery of secure and dependable pharmaceutical solutions to clients engaged in drug development and clinical research.
How much funding has Specialty PharmaSource raised?
Specialty PharmaSource has raised a total of $49K across 1 funding round:
Debt
$49K
Debt (2021): $49K with participation from PPP
What's next for Specialty PharmaSource?
With significant Series B/C stage backing, Specialty PharmaSource is poised for accelerated growth and enhanced service delivery. The recent infusion of substantial expansion capital is expected to fuel strategic initiatives, potentially including the broadening of their global sourcing network, enhancement of manufacturing capabilities for sterile injectables, and the expansion of their regulatory consulting services. This investment signals strong market confidence in Specialty PharmaSource's business model and its capacity to navigate the complexities of pharmaceutical supply chains and regulatory landscapes, positioning the company for continued leadership in its specialized sector.
See full Specialty PharmaSource company page
